Hypertriglyceridemia in a pediatric referral practice: Experience with 300 patients

Clinical Pediatrics

Volumn 50, Issue 4, 2011, Pages 297-307

  De Ferranti, Sarah D ^a   Crean, Sheila ^b   Cotter, Jill ^c   Boyd, Dylan ^b   Osganian, Stavroula K ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

child; hypertriglyceridemia; treatment

Indexed keywords

ANTILIPEMIC AGENT; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CHILD; CONTROLLED STUDY; DIET; DISEASE COURSE; FEMALE; HOSPITAL; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PATIENT REFERRAL; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PROFESSIONAL PRACTICE; PSYCHIATRIC DIAGNOSIS; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; OBESITY; OVERWEIGHT; PEDIATRICS; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 79953079885     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922810379498     Document Type: Article

References (37)

1. Hokanson JE, Austin MA Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996 ; 3: 213-219. (Pubitemid 26266496)
2. Assmann G., Cullen P., Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J. 1998 ; 19 (Suppl A): A2 - A11.
3. Criqui MH, Heiss G., Cohn R., et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993 ; 328: 1220-1225. (Pubitemid 23115700)
4. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000 ; 86: 943-949.
5. Hopkins PN, Wu LL, Hunt SC, Brinton EA Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol. 2005 ; 45: 1003-1012. (Pubitemid 40432430)
6. Yuan G., Al Shali KZ, Hegele RA Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007 ; 176: 1113-1120. (Pubitemid 46649735)
7. Hodis HN, Mack WJ, Krauss RM, Alaupovic P. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol. 1999 ; 22 (6 Suppl): 1115-1120.
8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497.
9. Clark JM The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006 ; 40 (Suppl 1). S5 - S10.
10. Athyros VG, Mikhailidis DP, Didangelos TP, et al. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin. 2006 ; 22: 873-883. (Pubitemid 43875555)
11. Green ML Evaluation and management of dyslipidemia in patients with HIV infection. J Gen Intern Med. 2002 ; 17: 797-810. (Pubitemid 35286246)
12. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004 ; 27: 596-601.
13. Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002 ; 287: 356-359. (Pubitemid 34251969)
14. Daniels SR, Greer FR Lipid screening and cardiovascular health in childhood. Pediatrics. 2008 ; 122: 198-208.
15. McGill HC Jr, McMahan CA Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol. 1998 ; 82 (10B). 30T - 36T.
16. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol. 1991 ; 133: 884-899.
17. de Ferranti SD, Gauvreau K., Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004 ; 110: 2494-2497. (Pubitemid 39407358)
18. Steinberger J., Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009 ; 119: 628-647.
19. Davis CL, Flickinger B., Moore D., Bassali R., Domel BS, Yin Z. Prevalence of cardiovascular risk factors in school-children in a rural Georgia community. Am J Med Sci. 2005 ; 330: 53-59. (Pubitemid 41140459)
20. Reis EC, Kip KE, Marroquin OC, et al. Screening children to identify families at increased risk for cardiovascular disease. Pediatrics. 2006 ; 118: e1789 - e1797.
21. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999 ; 103 (6Pt1). 1175-1182. (Pubitemid 29258789)
22. Manlhiot C., Larsson P., Gurofsky RC, et al. Spectrum and management of hypertriglyceridemia among children in clinical practice. Pediatrics. 2009 ; 123: 458-465.
23. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000 ;(314). 1-27.
24. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004 ; 114 (2Suppl4th Report). 555-576.
25. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr. 2003 ; 142: 368-372. (Pubitemid 36521221)
26. Jeppesen J., Hein HO, Suadicani P., Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998 ; 97: 1029-1036.
27. Yarnell JW, Patterson CC, Sweetnam PM, et al. Do total and high density lipoprotein cholesterol and triglycerides act independently in the prediction of ischemic heart disease? Ten-year follow-up of Caerphilly and Speedwell Cohorts. Arterioscler Thromb Vasc Biol. 2001 ; 21: 1340-1345. (Pubitemid 34219842)
28. Bae JH, Bassenge E., Kim KB, et al. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 2001 ; 155: 517-523. (Pubitemid 32209324)
29. Bansal S., Buring JE, Rifai N., Mora S., Sacks FM, Ridker PM Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 ; 298: 309-316. (Pubitemid 47080485)
30. Nordestgaard BG, Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007 ; 298: 299-308. (Pubitemid 47080484)
31. Cohen JC, Boerwinkle E., Mosley TH Jr, Hobbs HH Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006 ; 354: 1264-1272.
32. Harris WS, Ginsberg HN, Arunakul N., et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997 ; 4: 385-391. (Pubitemid 28078682)
33. Pownall HJ, Brauchi D., Kilinç C., et al. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis. 1999 ; 143: 285-297. (Pubitemid 29166909)
34. Buyukcelik M., Anarat A., Bayazit AK, et al. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome. Turk J Pediatr. 2002 ; 44: 40-44. (Pubitemid 34141389)
35. Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newburger JW Niacin treatment of hypercholesterolemia in children. Pediatrics. 1993 ; 92: 78-82. (Pubitemid 23188871)
36. Harris WS n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997 ;65(5 Suppl): 1645S - 1654S.
37. Engler MM, Engler MB, Malloy M., et al. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther. 2004 ; 42: 672-679. (Pubitemid 39625126)